EUVIMEDEUVIMED entdecken
Crossref

Determination and mechanism of Xiao-Ai Jie-Du decoction against diffuse large B-cell lymphoma: In silico and In vitro studies

Xin-Zhuo Zhan, Tian-Hua Wei, Yu-Qi Yin, Jian-Qiao Xu, Hui Yu, Xiao-Li Chen, Xiang-Tu Kong, Shan-Liang Sun, Nian-Guang Li, Hai-Wen Ni

Journal of Ethnopharmacology · 2024

DOI: 10.1016/j.jep.2023.117271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2024. Verfasst von Xin-Zhuo Zhan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China; The First Clinical College of Nanjin…. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Drugs, Chinese Herbal. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Xiao-Ai Jie-Du decoction (XAJDD) has been used in clinical practice to treat diffuse large B-cell lymphoma (DLBCL); its prescriptions vary based on the pathogenesis of patients. AIM OF THE STUDY: We aimed to determine the core formula of XAJDD and investigate its mechanism of action against DLBCL. MATERIALS AND METHODS: Apriori data mining of 187 clinical cases (including 421 Traditional Chinese Medicines, TCMs) was conducted to retrieve the core formula of XAJDD. Comprehensive in silico modeling was used to identify potential active components and corresponding targets. The potential targets of 16 compounds were identified based on network pharmacology using in silico modeling. Thereafter, experimental determination of the active compounds and their mechanism of action in treating DLBCL was performed using different assays (including CCK-8, Annexin V-FITC/PI double-staining, Western blot, and flow cytometry assays). RESULTS: The core formula of XAJDD included six herbs: Astragalus mongholicus Bunge (Huangqi, family: Fabaceae), Scutellaria barbata D. Don (Banzhilian, family: Lamiaceae), Prunella vulgaris L. (Xiakucao, family: Lamiaceae), Smilax glabra Roxb. (Tufuling, family Smilacaceae) and Fritillaria thunbergii Miq. (Dabei, family: Liliaceae), and Curcuma zanthorrhiza Roxb. (Ezhu, family: Zingiberaceae); Databases including 62 druggable compounds and 38 DLBCL-related structural targets were constructed; ∼0.3 million data points produced by computational modeling based on potential compounds and targets six components from XAJDD, including astibin, folic acid, baicalin, kaempferol, quercetin, and luteolin, significantly inhibited DLBCL cell proliferation, induced apoptosis, and suppressed the expression of key oncogenes. CONCLUSION: This study provides an integrated strategy for determining the core formula of XAJDD and reveals the molecular mechanisms underlying the treatment of DLBCL, which were consistent with the principle of "monarch (Jun), minister (Chen), adjunctive (Zuo), and guide (Shi)", confirming that XAJDD may serve as a promising natural therapeutic agent against DLBCL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseDrugs, Chinese HerbalHumansApoptosisBiological AssayBlotting, WesternComputer SimulationMolecular Docking Simulation

Stichwörter der Autor:innen

Diffuse large B-cell lymphomaMechanismMolecular modelingPharmacologyXiao-Ai Jie-Du decoction

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of Hematology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China; The First Clinical College of Nanjing University of Chinese Medicine, Nanjing, 210023, China. Electronic a…
  • National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrializa…
  • Department of Hematology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China. Electronic address: yuhui80@outlook.com.
  • Department of Hematology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China. Electronic address: cc_lily2008@163.com.
  • Department of Hematology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China. Electronic address: kongxiangtu@njucm.edu.cn.
  • Department of Hematology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China. Electronic address: fsyy00654@njucm.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhan, X. Z., Wei, T. H., Yin, Y. Q., Xu, J. Q., Yu, H., Chen, X. L., Kong, X. T., Sun, S. L., Li, N. G., & Ni, H. W. (2024). Determination and mechanism of Xiao-Ai Jie-Du decoction against diffuse large B-cell lymphoma: In silico and In vitro studies. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2023.117271

Vancouver

Zhan XZ, Wei TH, Yin YQ, Xu JQ, Yu H, Chen XL, et al. Determination and mechanism of Xiao-Ai Jie-Du decoction against diffuse large B-cell lymphoma: In silico and In vitro studies. Journal of Ethnopharmacology. 2024. doi:10.1016/j.jep.2023.117271

BibTeX
@article{Zhan2024,
  author = {Zhan, Xin-Zhuo and Wei, Tian-Hua and Yin, Yu-Qi and Xu, Jian-Qiao and Yu, Hui and Chen, Xiao-Li and Kong, Xiang-Tu and Sun, Shan-Liang and Li, Nian-Guang and Ni, Hai-Wen},
  title = {Determination and mechanism of Xiao-Ai Jie-Du decoction against diffuse large B-cell lymphoma: In silico and In vitro studies},
  journal = {Journal of Ethnopharmacology},
  year = {2024},
  doi = {10.1016/j.jep.2023.117271}
}
Kostenlos starten →